logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Attention Deficit Hyperactivity Disorder

    FiltersReset Filters
    44 results

    • amphetamine sulfate

      (Amphetamine Sulfate)
      Granules Pharmaceuticals Inc.
      Usage: Amphetamine sulfate tablets are indicated for narcolepsy, Attention Deficit Disorder with Hyperactivity in conjunction with a comprehensive treatment program, and as a short-term adjunct for exogenous obesity in patients not responding to other weight loss strategies.

    • amphetamine sulfate

      (amphetamine sulfate)
      Lannett Company, Inc.
      Usage: Amphetamine sulfate tablets (5 mg and 10 mg) are indicated for narcolepsy, Attention Deficit-Disorder with Hyperactivity as part of a comprehensive treatment program, and short-term management of exogenous obesity as an adjunct to a caloric restriction regimen in patients unresponsive to other therapies.

    • atomoxetine hydrochloride

      (atomoxetine hydrochloride)
      Apotex Corp.
      Usage: Atomoxetine capsules are indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in pediatric and adult patients. It should be part of a comprehensive treatment program that may include psychological, educational, and social interventions, and is not suitable for those with symptoms due to environmental factors or other psychiatric disorders.

    • azstarys

      (Serdexmethylphenidate and Dexmethylphenidate)
      Corium, LLC.
      Usage: AZSTARYS is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older.

    • chlorpromazine hydrochloride

      (chlorpromazine hydrochloride)
      Camber Pharmaceuticals, Inc.
      Usage: This drug is indicated for treating schizophrenia, controlling nausea and vomiting, and relieving restlessness before surgery. It also addresses acute intermittent porphyria, aids in tetanus treatment, manages mania, treats intractable hiccups, and handles severe behavioral issues in children aged 1 to 12, including hyperactivity and conduct disorders.

    • chlorpromazine hydrochloride

      (CHLORPROMAZINE HYDROCHLORIDE)
      Eugia US LLC
      Usage: This drug is indicated for treating schizophrenia, controlling nausea and vomiting, managing pre-surgical anxiety, acute intermittent porphyria, tetanus alongside other treatments, and addressing manic episodes. It also helps alleviate intractable hiccups and severe behavioral issues in children aged 1 to 12, including hyperactivity and conduct disorders.

    • clonidine hydrochloride

      (Clonidine Hydrochloride)
      Somerset Therapeutics, LLC
      Usage: Clonidine hydrochloride extended-release tablets are indicated for treating attention deficit hyperactivity disorder (ADHD), both as a standalone treatment and as an adjunct to stimulant medications.

    • concerta

      (Methylphenidate hydrochloride)
      Janssen Pharmaceuticals, Inc.
      Usage: CONCERTA is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 and older, adolescents, and adults up to 65 years old.

    • dexedrine

      (dextroamphetamine sulfate)
      Amneal Pharmaceuticals LLC
      Usage: DEXEDRINE is indicated for the treatment of narcolepsy and Attention Deficit Disorder with Hyperactivity (ADHD) in children aged 6 to 16 years, as part of a comprehensive treatment program that may include psychological and educational interventions. It is not intended for symptoms caused by environmental factors or primary psychiatric disorders.

    • dexmethylphenidate hydrochloride

      (Dexmethylphenidate hydrochloride)
      Amneal Pharmaceuticals of New York LLC
      Usage: Dexmethylphenidate hydrochloride extended-release capsules are indicated for treating Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older, as part of a comprehensive treatment program. Its long-term effectiveness has not been systematically evaluated beyond 7 weeks.